Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-02-18 | New | $540,183 | $540,183 | Equity Only | 06b | SEC link |
| 2023-01-04 | New | $100,000 | $100,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Mark Cochran | Director |
| Peter C. Doyle | Director, Executive |
| John Howison Schroeder | Director, Executive |
| Blynn L. Schideler | Director |
| John Howison Schroeder | Director, Executive |